< previous page page_256 next page >

Page 256
Toward the end of the eighties and beginning of the nineties, Iopamidol sales peaked in all major markets. The company grew enthusiastically and the atmosphere inspired a great sense of pride and security. In this period, however, Bracco's traditional competitor Schering launched its first contrast medium in a new imaging modality, magnetic resonance imaging, and voices were also being heard about Nycomed being launched shortly.
It was then that the first doubts about Bracco's competitiveness arose, especially with regard to the time required to develop a new contrast medium. Project Management was proposed as a managerial tool to gain time. Soon afterwards, in 1991, an outsider with experience in preclinical and clinical development was employed in the position of Pilot Project Leader. The first move toward a matrix organization had been made (see Table 1 for a summary of the changes).
TABLE 1
Changes in R&D, Bracco Group
1991 Weak Matrix Local Development Step 1: One Pilot Project Leader Milan
darr.gif
Trial: first Project
Europeization
1992 Weak Matrix EU Development
3a2af372a540e460b69ba6aec2b32999.gif
Step 2: Seven development projects, Milan, Geneva, coordination Japan, Executive Committee R&D, Director Project Planning and Head of Project Coordination
darr.gif
Trial: Multiproject
1995 Weak Matrix Worldwide
3a2af372a540e460b69ba6aec2b32999.gif
Step 3: Nine development projects, each with a Team in the U.S. and Europe and an Executive Committee R&D with U.S. and European delegates; Development Director with international budget responsibility; Heads of Project Management in EU and U.S.
darr.gif
Trial: Worldwide projects
Globalization
darr.gif
3a2af372a540e460b69ba6aec2b32999.gif
Extension to research and centralization
1996 Strong Matrix in R&D
3a2af372a540e460b69ba6aec2b32999.gif
Step 4: Nine international development projects guided by central International Project Leader with full responsibility for time and resources
Research organized in programs with Program Leader
R&D led by Co-Director Portfolio and Co-Director Resources
Corporate Project Planning, Strategic Product Group at headquarters

 
< previous page page_256 next page >